Weekly Executive & Director Moves (Aug 12)

by | Aug 12, 2022

Boardroom Alpha provides in-depth analytics and tracking of all public company executives and officers. Below is a rundown of people moves made at notable companies this past week. Get a demo today to see how you can receive real-time alerts and in-depth analytics.

Moves in this Issue

CEO

AGIO, CAH, CDXS, CG, CMTL, FLNC, FRBK, LNDC, MSTR, OTRK

CFO

AMCX, AMR, ASMB, AXON, BCO, BWEN, CAH, CDXC, CECE, CMCT, GRWG, GSBD, HLLY, HSC, IMRX, JKHY, MIGI, OBNK, OTIS, PET, PFGC, SONO, TUEM, USAC, UUUU, X

Directors

ACC, AGIO, AGL, AIT, ALBO, ALSN, AMAL, AME, AOUT, AQST, ARGO, AVTX, BSQR, CADL, CAH, CBL, CDXC, CG, CING, CMTL, CNR, DRTT, EAR, EMN, FLNC, GRTS, HIPO, HOFV, INM, INTC, ISPO, JBLU, LNDC, LNW, MNMD, MOG.A, NMRK, NN, NUE, OWLT, PAYS, PD, QTRX, RAMP, RDBX, RIVN, RKLY, RVLP, SF, SMAR, SPIR, SWX, TGT, TNC, TWIN, UDMY, VCYT, VERV, VIRX, VRT, WE, WISH

CEO Moves

CARDINAL HEALTH INC (CAH)
Leaving: CEO – Michael C Kaufmann ( 4.7 yrs; 2.9% TSR)
Replaced by: Jason M Hollar

Mr. Hollar has served as Chief Financial Officer (“CFO”) of the Company since May 2020. He previously served as Executive Vice President and CFO of Tenneco Inc. from July 2018 to April 2020. He was Senior Vice President Finance at Tenneco Inc. from June 2017 to June 2018 and CFO of Sears Holding Corporation from October 2016 to April 2017. In connection with Mr. Hollar assuming the CEO role, the B…read full bio

CARLYLE GROUP INC (CG)
Leaving: CEO – Kewsong Lee ( 4.6 yrs; 15.6% TSR)
Replaced by: William E Conway Jr

Mr. Conway, age 72, is a Co-Founder of the Company and current Non-Executive Co-Chairman of the Board. Mr. Conway was elected to the Board effective July 18, 2011. Previously, Mr. Conway served as the Company’s Co-Chief Executive Officer and Chief Investment Officer. Prior to forming the Company in 1987, Mr. Conway was the Senior Vice President and Chief Financial Officer of MCI Communications Cor…read full bio

CODEXIS INC (CDXS)
Leaving: CEO – John J Nicols ( 10.2 yrs; 9.1% TSR)
Replaced by: Stephen George Dilly

Stephen G. Dilly, M.B.B.S., Ph.D. , has served as a director of Codexis since June 2020. Dr. Dilly brings to our board of directors extensive management experience in the life science industry and drug development experience. Since May 2020 Dr. Dilly has served as Chief Executive Officer of Sierra Oncology and as a member of Sierra’s board of directors. Dr. Dilly previously served as Chief Executi…read full bio

FLUENCE ENERGY INC (FLNC)
Leaving: CEO – Manuel Perez Dubuc ( .8 yrs; -70.6% TSR)
Replaced by: Julian Nebreda

Mr. Nebreda will continue to serve as a member of the Company’s Board but has stepped down as a member of the Compensation Committee of the Board, effective as of August 5, 2022. Prior to Mr. Nebreda’s appointment at the Company, Mr. Nebreda, age 56, most recently served as Executive Vice President and President of US & Global Business Lines for The AES Corporation (“AES”) since January 2022. Mr. …read full bio

LANDEC CORP (LNDC)
Leaving: CEO – Albert D Bolles ( 8.6 yrs; -1.8% TSR)
Replaced by: James G Hall

Mr. Hall has served as Vice President of the Company and President of Lifecore Biomedical, Inc. (” Lifecore “), a wholly owned biomedical subsidiary of the Company, since June 2017. At Lifecore, Mr. Hall served as Vice President and General Manager from July 2013 to June 2017; Vice President of Operations from 2006 to 2013; Director of Manufacturing Operations and Engineering from 2001 to 2006; an…read full bio

MICROSTRATEGY INC (MSTR)
Leaving: CEO – Michael J Saylor ( 32.8 yrs; 3.4% TSR)
Replaced by: Phong Le

Phong Le has served as President since July 2020 and has also served in various other senior executive positions since joining MicroStrategy in 2015, including Chief Financial Officer and Chief Operating Officer. Mr. Le has successfully managed the operations of the Company, delivering one of the best operational and financial years in the history of the Company’s software business in 202…read full bio

ONTRAK INC (OTRK)
Leaving: CEO – Jonathan E Mayhew ( 1.3 yrs; -92.2% TSR)
Replaced by: Terren S Peizer

Terren S. Peizer is the founder of our Company and an entrepreneur, investor, and financier with a vested interest in healthcare, having founded and successfully commercialized several healthcare companies. He has served as Chairman of the Board of Directors since the Company’s inception in 2003 through April 11, 2021. Effective April 12, 2021, Mr. Peizer was appointed to serve as the Executive Ch…read full bio

REPUBLIC FIRST BANCORP INC (FRBK)
Leaving: CEO – Vernon W Hill II ( 1.5 yrs; 14.1% TSR)
Replaced by: TBD

CFO Moves

ASSEMBLY BIOSCIENCES INC (ASMB)
Leaving: CFO – Michael P Samar ( 1.2 yrs; -39.7% TSR)
Replaced by: Jason A Okazaki

Jason A. Okazaki 46 Mr. Okazaki has served as our Chief Operating Officer since August 2021. Mr. Okazaki served as our Chief Legal and Business Officer from March 2020 until his promotion to Chief Operating Officer. Prior to joining us, Mr. Okazaki served in a series of positions of increasing responsibility in Gilead’s legal department from 2006 until March 2020, culminating in his role as Senior…read full bio

BROADWIND INC (BWEN)
Leaving: CFO – Eric B Blashford ( .8 yrs; -36.8% TSR)
Replaced by: Thomas A Ciccone

Thomas A. Ciccone has served as our Principal Accounting Officer and Vice President since October 1, 2021. Prior to that Mr. Ciccone served as Corporate Controller, Assistant Treasurer and Assistant Secretary from July 2017 to September 2021. He joined Broadwind in 2008 as Accounting Manager, and has since held various corporate finance roles including Director of Finance and Manager of External R…read full bio

CARDINAL HEALTH INC (CAH)
Leaving: CFO – Jason M Hollar ( 2.3 yrs; 11.3% TSR)
Replaced by: Patricia M English

Ms. English has served as Senior Vice President and Chief Accounting Officer of the Company since September 2020. She previously served as Vice President, Pharmaceutical Segment Accounting from January 2019 to August 2020. She served as Vice President, Medical Segment Accounting from March 2015 to December 2018 and as Director, Pharmaceutical Distribution Accounting from June 2011 to March 2015. I…read full bio

CHROMADEX CORP (CDXC)
Leaving: CFO – Kevin M Farr ( 4.8 yrs; -15.4% TSR)
Replaced by: Brianna Gerber

Ms. Gerber, age 42, previously served as Vice President of Finance and Investor Relations of ChromaDex, Inc. since September 17, 2018, and prior to that served in multiple leadership roles at Mattel, Inc. since 2013. Ms. Gerber received her B.S. in Corporate Finance and Entrepreneurship from the University of Southern California. She is a Chartered Financial Analyst (CFA) and member of the CF…read full bio

CREATIVE MEDIA & COMMUNITY TRUST CORP (CMCT)
Leaving: CFO – Nathan David Debacker ( 3.4 yrs; -16.8% TSR)
Replaced by: Barry N Berlin

Mr. Berlin has been the Executive Vice President of the Company since October 2008 and was Chief Financial Officer of the Company’s predecessor from June 1993 to March 2014. He has been Chief Financial Officer of the Company’s wholly-owned subsidiary lending business since 1992 and has been the Chief Executive Officer and Chairman of the Board of Directors of that business since 2020. In addition,…read full bio

ENERGY FUELS INC (UUUU)
Leaving: CFO – David C Frydenlund ( 4.4 yrs; 35.3% TSR)
Replaced by: Tom L Brock

Mr. Brock began his career with KPMG LLP, where he spent 13 years holding various positions serving clients in the energy industry. Mr. Brock holds a Bachelor of Accountancy from New Mexico State University and is a Certified Public Accountant licensed in the State of Texas. In connection with his appointment as CFO, Mr. Brock entered into an employment agreement with the Company (the “Employment …read full bio

GOLDMAN SACHS BDC INC (GSBD)
Leaving: CFO – Carmine Rossetti ( .8 yrs; -2.9% TSR)
Replaced by: David Pessah

David Pessah . Mr. Pessah was appointed as Principal Accounting Officer of the Company in March 2020. Mr. Pessah is also Principal Accounting Officer of PMMC, PMMC II and MMLC II. Mr. Pessah is a Vice President in the BDC Fund Controllers team of the Investment Adviser. Mr. Pessah is responsible for fund accounting and financial reporting oversight as well as the continuous improvement of the Comp…read full bio

HENRY JACK & ASSOCIATES INC (JKHY)
Leaving: CFO – Kevin D Williams ( 21.7 yrs; 10.6% TSR)
Replaced by: Mimi Carsley

Ms. Carsley, age 52, joined the Company as the Executive Vice President of Finance on July 1, 2022. Prior to joining the Company, Ms. Carsley served in various roles for Blucora, Inc. (Nasdaq: BCOR), including as Treasurer and Senior Vice President of Financial Planning & Analysis and Procurement from 2020 to 2022, as Interim Chief Financial Officer in 2020, and as a Financial Consultant contracto…read full bio

HOLLEY INC (HLLY)
Leaving: CFO – Dominic Bardos ( 1.1 yrs; -6.5% TSR)
Replaced by: Stephen Trussell

Stephen Trussell, the Company’s current Vice President of Finance, will serve as interim Chief Financial Officer, effective upon Mr. Bardos’s departure. During the period when Mr. Trussell is serving as interim Chief Financial Officer, his annual base salary will be increased to $346,000. Mr. Trussell, (54), has been with Holley since 2003. He currently serves as Vice President of Finance, and pre…read full bio

IMMUNEERING CORP (IMRX)
Leaving: CFO – Biren Amin ( 1.3 yrs; -58.1% TSR)
Replaced by: Mallory Morales

Ms. Morales, 39, has served as the Company’s Vice President, Finance since May 2021. Prior to joining the Company, Ms. Morales served as Strategic Finance Business Partner at Gilead Sciences, Inc. (“Gilead”), a biopharmaceutical company, from October 2020 to May 2021, where she oversaw the integration of the research and development organization of Immunomedics, Inc. (“I…read full bio

MAWSON INFRASTRUCTURE GROUP INC (MIGI)
Leaving: CFO – Hetal Majithia ( 1.0 yrs; -86.5% TSR)
Replaced by: Mr. Ariel Sivikofsy

Mr. Sivikofsky has more than 15 years of experience as a senior finance executive primarily in financial services and accounting both in Australia and internationally. Prior to DSS, Mr. Sivikofsky acted as CFO for the biotechnology companies Koligo Therapeutics Ltd, Luoda Pharm Ltd and Bova Specials UK Ltd. Mr. Sivikofsky is a seasoned finance executive undertaking Chief Financial Officer and C…read full bio

OTIS WORLDWIDE CORP (OTIS)
Leaving: CFO – Rahul Ghai ( 2.3 yrs; 25.6% TSR)
Replaced by: Anurag Maheshwari

 Mr. Maheshwari, 48, has worked at the Company since February 2020 as its Vice President, Finance, Information Technology and Chief Transformation Officer, Otis Asia Pacific. Prior to that, Mr. Maheshwari most recently served as Vice President, Investor Relations for Harris Corporation from 2017 to 2019 and for L3 Harris Technologies from 2019 to 2020….read full bio

PERFORMANCE FOOD GROUP CO (PFGC)
Leaving: CFO – James D Hope ( 4.8 yrs; 11.0% TSR)
Replaced by: Patrick Hatcher

Mr. Hatcher has served as President and Chief Operating Officer of Vistar since 2021. Mr. Hatcher joined Vistar in 2010 and served as Senior Vice President and Chief Financial Officer of Vistar from 2010 to 2015 and Senior Vice President of Sales and Marketing from 2015 to 2021. Prior to joining Vistar, he spent approximately 10 years with MillerCoors in finance and numerous other functions. Mr. H…read full bio

SONOS INC (SONO)
Leaving: CFO – Brittany Bagley ( 3.4 yrs; 24.0% TSR)
Replaced by: Eddie Lazarus

Edward Lazarus has served as our Chief Legal Officer and Corporate Secretary since January 2019. From January 2013 to December 2018, Mr. Lazarus served as the Executive Vice President, General Counsel and Corporate Secretary of Tribune Media Company. Prior to Tribune, Mr. Lazarus worked as an independent consultant and attorney from February 2012 to January 2013 and se…read full bio

TUESDAY MORNING CORP (TUEM)
Leaving: CFO – Jennifer N Robinson ( .9 yrs; -93.0% TSR)
Replaced by: Marc Katz

Marc D. Katz. Mr. Katz, age 57, has served as Principal and Chief Operating Officer of the Company since September 9, 2021. From May 18, 2021 to September 14, 2021, Mr. Katz served as Interim Chief Financial Officer of the Company. Mr. Katz worked at Burlington Stores, Inc. from 2008 through 2019 with his last position being Chief Financial Officer/Principal. During his tenure at Burlington, he ov…read full bio

Director Joins

ALBIREO PHARMA INC (ALBO)
Susan Alesina

Ms. Alesina, age 59, has served as Vice President, National Business Development and Alliances, at Boston Children’s Hospital since September 2015. In this role, she leads efforts to identify and develop strategic partnerships with national health systems and hospital providers to…read full bio

ALBIREO PHARMA INC (ALBO)
Habib J Dable

Mr. Dable, age 53, has been an Independent Director at Blueprint Medicines Corporation (Nasdaq: BPMC), a global precision therapy company developing therapies for people with cancer and blood disorders, since June 2022, and a part-time Venture Partner at RA Ventures since April 2022. He…read full bio

ALLISON TRANSMISSION HOLDINGS INC (ALSN)
Gustave F. Perna

General, United States Army (retired) Perna retired from the United States Army in July 2021 as the Chief Operating Officer of Operation Warp Speed, the Trump administration’s multi-billion-dollar coronavirus vaccine and treatment effort, a position he had held since May 2020. Prior to that…read full bio

ALLISON TRANSMISSION HOLDINGS INC (ALSN)
Sasha Ostojic

Shivram currently serves as Director of Ranger Energy Services Inc. since August 2017 and of Superior Energy Services Inc. since April 2021, both of which are oilfield service companies, as well as Director of Sentinel Energy Services Inc., a special purpose acquisition company, since Novemb…read full bio

AMETEK INC (AME)
Suzanne Stefany

Prior to joining PJT Partners in 2017, Ms. Stefany served as Managing Director, Global Industry Analyst for Wellington Management from 2005 where she managed portfolio mandates covering the U.S., Europe, and Asia. She als…read full bio

APPLIED INDUSTRIAL TECHNOLOGIES INC (AIT)
Shelly Marie Chadwick

Ms. Chadwick, age 50, was elected for a term expiring in October 2024. Since November 2020, she has served as Vice President, Finance and Chief Financial Officer for Materion Corporation (NYSE: MTRN), a global high-tech solutions provider of performance alloys, advanced materials, and precision opti…read full bio

CARDINAL HEALTH INC (CAH)
Jason M Hollar

Mr. Hollar has served as Chief Financial Officer (“CFO”) of the Company since May 2020. He previously served as Executive Vice President and CFO of Tenneco Inc. from July 2018 to April 2020. He was Senior Vice President Finance at Tenneco Inc. from June 2017 to June 2018 and CFO of Sears Holding Cor…read full bio

CBL & ASSOCIATES PROPERTIES INC (CBL)
Jeffrey Kivitz

Mr. Kivitz is a Partner with Canyon Partners, LLC (together with its affiliates, “Canyon”).  He is responsible for the firm’s investments in companies across the REIT, technology, software, building products and retail sectors.  Prior to joining Canyon in 200…read full bio

CONTEXTLOGIC INC (WISH)
Lawrence M Kutscher

Mr. Kutscher is currently the Chief Executive Officer of A Place for Mom, Inc., a technology-driven senior living referral company, leading the company since April 2019 on its mission to enable caregivers to make the best senior living decisions. He has over 20 years of executive leadership and e…read full bio

INMED PHARMACEUTICALS INC (INM)
Nicole Lemerond

Nicole Lemerond is a financial executive with over 25 years of experience in investment management, private equity, investment banking and leveraged finance. She has significant experience executing complex transactions, managing diligence processes, raising capital and struc…read full bio

INSPIRATO INC (ISPO)
Scott Berman

Scott Berman previously served as a Partner in the hospitality and leisure consulting practice at PricewaterhouseCoopers LLP (” PwC “), a global accounting firm, from 1992 to 2022, and served as PwC’s U.S. hospitality and leisure practice leader from 2007 until his retirement in June 2022. While at …read full bio

JETBLUE AIRWAYS CORP (JBLU)
Nikhil Mittal

Mr. Mittal is currently president and co-portfolio manager of Molecule Ventures LLC, a private environmental markets investment firm he co-founded, partner and lead investor in Plankton Energy LLC, a community solar developer, and an advisor to CleanPlanet Chemical, a solvent waste management and re…read full bio

LANDEC CORP (LNDC)
James G Hall

Mr. Hall has served as Vice President of the Company and President of Lifecore Biomedical, Inc. (” Lifecore “), a wholly owned biomedical subsidiary of the Company, since June 2017. At Lifecore, Mr. Hall served as Vice President and General Manager from July 2013 to June 2017; Vice President of Oper…read full bio

MOOG INC (MOG.A)
Mahesh NarangMr. Narang, age 47, is President of the Components segment at Cummins Inc., a role he assumed in March 2021. Prior to that, he served as the Vice President and General Manager of Cummins Emission Solutions….read full bio

NEWMARK GROUP INC (NMRK)
Jay Itzkowitz

Mr. Itzkowitz was also appointed to the Audit and Compensation Committees of the Board. Mr. Itzkowitz, age 62, is an experienced real estate and mergers and acquisitions attorney. Mr. Itzkowitz is currently the Executive Vice President and General Counsel of S.D. Malkin Properties, a Connecticut-bas…read full bio

PAGERDUTY INC (PD)
William E LoschMr. Losch, age 61, served as the Chief Financial Officer of Okta, Inc., an identity management platform for enterprises, from June 2013 until his retirement in March 2021. From June 2007 to June 2013, he served as the Chief Financial Officer at MobiTV, Inc., a technology platform provider of mu…read full bio

PAYSIGN INC (PAYS)
Matthew Louis Lanford

Matt Lanford, Chief Operating Officer and President . Mr. Lanford has served as our Chief Operating Officer and President since February 2021. Mr. Lanford served as the Company’s Chief Product Officer from 2019 to 2021. Prior to joining our company, Mr. Lanford served as senior vice president and ge…read full bio

ROCKLEY PHOTONICS HOLDINGS LTD (RKLY)
Richard KuntzDr. Kuntz brings to the Board a blend of world-class industry, clinical and research experience. Most recently, Dr. Kuntz served as Medtronic’s Senior Vice President, Chief Medical and Scientific Officer. Dr. Kuntz joined Medtronic in 2005 as Senior Vice President and President of Medtron…read full bio

RVL PHARMACEUTICALS PLC (RVLP)
Alisa Lask

Ms. Lask was also appointed to serve on the Board’s Compensation Committee (the “Compensation Committee”) and Nominating and Corporate Governance Committee (the “Nominating and Corporate Governance Committee”). As part of her non-employee director compensation, Ms. Lask is expected to receive, subje…read full bio

SMARTSHEET INC (SMAR)
Dennis M DurkinMr. Durkin served as Chief Financial Officer of Activision Blizzard Inc. (“Activision”), an interactive entertainment and gaming corporation, from January 2019 until his retirement in May 2021. Prior to that, he served as Activision’s Chief Corporate Officer from May 2017 to J…read full bio

SOUTHWEST GAS HOLDINGS INC (SWX)
Ruby Sharma

Ms. Sharma is a multi-cultural, global business advisor with comprehensive expertise and skills in Strategy, Operational Risk Transformation, Mergers and Acquisitions, Governance, Audit and Accounting. Ms. Sharma has served as Managing Partner of RNB Strategic Advisors, a strategic advi…read full bio

STIFEL FINANCIAL CORP (SF)
Jim Kavanaugh

Jim Kavanaugh is the Co-Founder and CEO of World Wide Technology (WWT), a $14.5 billion Information Technology systems integrator and business partner to 70 of the Fortune 100 companies. Under his leadership, WWT has been named a “great place to work” by Fo…read full bio

TWIN DISC INC (TWIN)
Kevin M Olsen

Mr. Olsen is currently the President and Chief Executive Officer of Dorman Products, Inc. (NASDAQ: DORM) and also serves as a member of Dorman’s Board of Directors. Mr. Olsen previously served as Dorman’s Chief Financial Officer from 2016 to 2018. Dorman Products, Inc. is a leading su…read full bio

VERACYTE INC (VCYT)
Eliav Barr

Dr. Barr has built his distinguished career at Merck Research Laboratories (MRL), a division of Merck & Co., Inc., a multinational pharmaceutical company, where he has served as Head of Global Clinical Development and Chief Medical Officer since April 2022. In this role, he oversees developme…read full bio

VIRACTA THERAPEUTICS INC (VIRX)
Jane Chung

Ms. Chung will serve as a Class III director. In addition, Ms. Chung was appointed as a member of the Nominating & Governance Committee of the Board. Jane Chung, RPh, 51, has served as the Chief Commercial Officer at Sutro Biopharma since August 2021. From May 2015 to August 2021, Ms. Chung served i…read full bio

WEWORK INC (WE)
Alex Clavel

Mr. Clavel is the Chief Executive Officer of SoftBank Group International (“SBGI”). He serves as a director on various internal SoftBank and external portfolio company boards, including LDH Growth Corp…read full bio

Director Exits

AGILON HEALTH INC (AGL)
Michael L Smith ( 5.6 yrs; -14.0% TSR)

ALLISON TRANSMISSION HOLDINGS INC (ALSN)
Richard Vanfleet Reynolds ( 12.5 yrs; 6.5% TSR)
Committees: Audit, Compensation

ALLISON TRANSMISSION HOLDINGS INC (ALSN)
Tunon Alvaro Garcia ( 7.3 yrs; 8.1% TSR)
Committees: Audit, Finance

AMALGAMATED FINANCIAL CORP (AMAL)
Mr. Stephen R. Sleigh ()

AVALO THERAPEUTICS INC (AVTX)
Keith Maher ( .8 yrs; -88.5% TSR)

AVALO THERAPEUTICS INC (AVTX)
Steven Boyd ( 5.3 yrs; -7.8% TSR)
Committees: Nominating (and Governance)

CANDEL THERAPEUTICS INC (CADL)
Alan E Smith ( 1.1 yrs; -51.0% TSR)

CANDEL THERAPEUTICS INC (CADL)
Shaan-Chirag C Gandhi ( 1.1 yrs; -51.0% TSR)

CANDEL THERAPEUTICS INC (CADL)
Udi Meirav ( 1.1 yrs; -51.0% TSR)

CARDINAL HEALTH INC (CAH)
Michael C Kaufmann ( 4.7 yrs; 2.9% TSR)

CARLYLE GROUP INC (CG)
Kewsong Lee ( 4.6 yrs; 15.6% TSR)
Committees: Executive

COMTECH TELECOMMUNICATIONS CORP (CMTL)
Michael Porcelain ( .6 yrs; -68.8% TSR)

CONTEXTLOGIC INC (WISH)
Piotr Szulczewski ( 1.7 yrs; -78.4% TSR)

CORNERSTONE BUILDING BRANDS INC (CNR)
Jeffrey S Lee ( .1 yrs; )

CORNERSTONE BUILDING BRANDS INC (CNR)
Alena Brenner ( .1 yrs; )

DIRTT ENVIRONMENTAL SOLUTIONS LTD (DRTT)
Mary Garden ( .3 yrs; )

EARGO INC (EAR)
Peter Bisgaard ( 4.8 yrs; -86.6% TSR)

FLUENCE ENERGY INC (FLNC)
Manuel Perez Dubuc ( .8 yrs; -70.6% TSR)

GRITSTONE BIO INC (GRTS)
Richard A Heyman ( 6.8 yrs; -33.5% TSR)
Committees: Compensation, Nominating (and Governance)

LIVERAMP HOLDINGS INC (RAMP)
Richard P Fox ( 10.6 yrs; 7.3% TSR)
Committees: Audit, Executive

MIND MEDICINE (MINDMED) INC (MNMD)
Miri Halperin Wernli ( 2.5 yrs; 35.2% TSR)

NEXTNAV INC (NN)
Peter J Barris ( .8 yrs; -75.0% TSR)

OWLET INC (OWLT)
Michael P Abbott ( 2.0 yrs; -56.5% TSR)

PAYSIGN INC (PAYS)
Daniel Spence ( 16.4 yrs; 8.0% TSR)

QUANTERIX CORP (QTRX)
E Kevin Hrusovsky ( 8.2 yrs; -4.1% TSR)

SOUTHWEST GAS HOLDINGS INC (SWX)
Jose A Cardenas ( 11.6 yrs; 10.4% TSR)
Committees: Audit, Compensation, Nominating (and Governance)

UDEMY INC (UDMY)
Kenneth A Fox ( .8 yrs; -60.9% TSR)

VERVE THERAPEUTICS INC (VERV)
John M Evans ( 1.2 yrs; -28.5% TSR)

WEWORK INC (WE)
Michel Combes ( .8 yrs; -52.7% TSR)

<a href="https://www.boardroomalpha.com/author/draps/" target="_self">David Drapkin</a>

David Drapkin

Spent his formative years at Goldman Sachs and now embraces the start-up life in NYC. A long suffering Oakland (Las Vegas) Raiders fan and graduate of the Wharton School at the University of Pennsylvania. Semi-professional go-kart racer waiting for his shot.

More from Boardroom Alpha

SPAC Daily: Tuesday 9/14

Maxpro Acquisition (JMAC) penned the lone SPAC DA of the day, plus the rest of today’s news in the market.

Know Who Drives Return

Objective, data-driven assessments for every public company director and officer.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed. 

Executive Moves

Newsletter

Get it in your inbox weekly and don't miss a move